Picture of Instil Bio logo

TIL — Instil Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Brief: Instil Bio Announces Extension Of Cash Runway Beyond 2026

Jan 31 (Reuters) - Instil Bio Inc  TIL.O :
    * INSTIL BIO ANNOUNCES EXTENSION OF CASH RUNWAY BEYOND 2026
WITH
THE CONSOLIDATION OF RESEARCH AND DEVELOPMENT OPERATIONS TO ITS
MANCHESTER, U.K. SITE
    * INSTIL TO EXTEND PREVIOUSLY ANNOUNCED REDUCTION-IN-FORCE
TO
REDUCE US HEADCOUNT
    * INITIAL CLINICAL DATA FROM ITIL-306 PROGRAM EXPECTED IN
2023
    * EVALUATING POTENTIAL SALE/SUBLEASE OF TARZANA
MANUFACTURING
SITE, OTHER FACILITIES CURRENTLY UNDER LEASE, TO EXTEND CASH
RUNWAY

Source text for Eikon:  ID:nGNXSTygv 
Further company coverage:  TIL.O

Recent news on Instil Bio

See all news